Smoking and pathogenesis of psoriasis: A review of oxidative, inflammatory and genetic mechanisms

British Journal of Dermatology

Volumn 165, Issue 6, 2011, Pages 1162-1168

  Armstrong, A W ^a   Armstrong, E J ^b   Fuller, E N ^c   Sockolov, M E ^a   Voyles, S V ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; REACTIVE OXYGEN METABOLITE; STAT PROTEIN;

CELL ACTIVATION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; HEREDITY; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; KERATINOCYTE; MACROPHAGE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; SMOKING; SMOKING CESSATION;

ANIMALS; ANTIOXIDANTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; MICE; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; NICOTINE; NICOTINIC AGONISTS; OXIDANTS; PSORIASIS; REACTIVE NITROGEN SPECIES; SKIN; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 82255175512     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10526.x     Document Type: Review

References (79)

1. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41. (Pubitemid 44547793)
2. McDonald CJ, Calabresi P,. Psoriasis and occlusive vascular disease. Br J Dermatol 1978; 99: 469-75. (Pubitemid 9048948)
3. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010; 31: 1000-6.
4. Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009; 145: 700-3.
5. Shapiro J, Cohen AD, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2006; 56: 629-34.
6. Xiao J, Chen LH, Tu YT, et al. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 2009; 23: 1311-15.
7. Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009; 129: 2411-18.
8. Gisondi P, Fantin F, Del Giglio M, et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009; 218: 110-13.
9. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M,. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010; 37: 146-55.
10. Balci DD, Balci A, Karazincir S, et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 1-6.
11. Ena P, Madeddu P, Glorioso N, et al. High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol 1985; 40: 199-205.
12. Soy M, Yildiz M, Sevki Uyanik M, et al. [Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid-femoral (aortic) pulse-wave velocity measurement]. Rev Esp Cardiol 2009; 62: 96-9.
13. Mokdad AH, Marks JS, Stroup DF, Gerberding JL,. Actual causes of death in the United States, 2000. JAMA 2004; 291: 1238-45. (Pubitemid 38541668)
14. Mokdad AH, Marks JS, Stroup DF, Gerberding JL,. Correction: actual causes of death in the United States, 2000. JAMA 2005; 293: 293-4. (Pubitemid 40116077)
15. Michaelsson G, Gustafsson K, Hagforsen E,. The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J Am Acad Dermatol 2006; 54: 737-8.
16. O'Doherty CJ, MacIntyre C,. Palmoplantar pustulosis and smoking. Br Med J (Clin Res Ed) 1985; 291: 861-4. (Pubitemid 15248128)
17. Kavli G, Forde OH, Arnesen E, Stenvold SE,. Psoriasis: familial predisposition and environmental factors. Br Med J (Clin Res Ed) 1985; 291: 999-1000. (Pubitemid 16236075)
18. Bell LM, Sedlack R, Beard CM, et al. Incidence of psoriasis in Rochester, Minn, 1980-1983. Arch Dermatol 1991; 127: 1184-7.
19. Naldi L, Peli L, Parazzini F,. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol 1999; 135: 1479-84.
20. Setty AR, Curhan G, Choi HK,. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 2007; 120: 953-9. (Pubitemid 350011082)
21. Al-Rubaii A, Al-Ward N, Al-Waiz M,. The age of onset of psoriasis and its relationship to smoking habits and stressful life events. Saudi Med J 2003; 24: 108. (Pubitemid 36335982)
22. Bo K, Thoresen M, Dalgard F,. Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults. Dermatology 2008; 216: 40-5. (Pubitemid 350158735)
23. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34. (Pubitemid 41815842)
24. Jankovic S, Raznatovic M, Marinkovic J, et al. Risk factors for psoriasis: a case-control study. J Dermatol 2009; 36: 328-34.
25. Mills CM, Srivastava ED, Harvey IM, et al. Smoking habits in psoriasis: a case control study. Br J Dermatol 1992; 127: 18-21.
26. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-7. (Pubitemid 40981424)
27. Raychaudhuri SP, Gross J,. Psoriasis risk factors: role of lifestyle practices. Cutis 2000; 66: 348-52.
28. Zhang X, Wang H, Te-Shao H, et al. Frequent use of tobacco and alcohol in Chinese psoriasis patients. Int J Dermatol 2002; 41: 659-62. (Pubitemid 35252041)
29. Fortes C, Mastroeni S, Leffondre K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005; 141: 1580-4. (Pubitemid 41815850)
30. Gupta MA, Gupta AK, Watteel GN,. Cigarette smoking in men may be a risk factor for increased severity of psoriasis of the extremities. Br J Dermatol 1996; 135: 859-60. (Pubitemid 26375915)
31. Okayama Y,. Oxidative stress in allergic and inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005; 4: 517-19. (Pubitemid 41052420)
32. Pryor WA, Stone K,. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 1993; 686: 12-27.
33. Zhou Q, Mrowietz U, Rostami-Yazdi M,. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 2009; 47: 891-905.
34. Lowes MA, Chamian F, Abello MV, et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 2005; 102: 19057-62. (Pubitemid 43049565)
35. Cheng SE, Luo SF, Jou MJ, et al. Cigarette smoke extract induces cytosolic phospholipase A2 expression via NADPH oxidase, MAPKs, AP-1, and NF-kappaB in human tracheal smooth muscle cells. Free Radic Biol Med 2009; 46: 948-60.
36. Boeglin WE, Kim RB, Brash AR,. A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc Natl Acad Sci USA 1998; 95: 6744-9. (Pubitemid 28278051)
37. Hasnis E, Bar-Shai M, Burbea Z, Reznick AZ,. Cigarette smoke-induced NF-kappaB activation in human lymphocytes: the effect of low and high exposure to gas phase of cigarette smoke. J Physiol Pharmacol 2007; 58 (Suppl. 5): 263-74. (Pubitemid 351346673)
38. Dimon-Gadal S, Gerbaud P, Therond P, et al. Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis. J Invest Dermatol 2000; 114: 984-9. (Pubitemid 30252721)
39. Leveque N, Robin S, Muret P, et al. In vivo assessment of iron and ascorbic acid in psoriatic dermis. Acta Derm Venereol (Stockh) 2004; 84: 2-5. (Pubitemid 38168354)
40. Baz K, Cimen MY, Kokturk A, et al. Oxidant/antioxidant status in patients with psoriasis. Yonsei Med J 2003; 44: 987-90. (Pubitemid 38081563)
41. Isik B, Ceylan A, Isik R,. Oxidative stress in smokers and non-smokers. Inhal Toxicol 2007; 19: 767-9. (Pubitemid 47026974)
42. Severin E, Nave B, Stander M, et al. Total antioxidative capacity is normal in sera from psoriasis patients despite elevated bilirubin, tocopherol and urate levels. Dermatology 1999; 198: 336-9. (Pubitemid 29335724)
43. Rangasamy T, Misra V, Zhen L, et al. Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. Am J Physiol Lung Cell Mol Physiol 2009; 296: L888-900.
44. Perricone NV,. Method for the Topical Treatment of Psoriasis. US Patent # 5,122,5361992.
45. Naldi L, Parazzini F, Peli L, et al. Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol 1996; 134: 101-6. (Pubitemid 26029668)
46. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
47. Aicher A, Heeschen C, Mohaupt M, et al. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 2003; 107: 604-11. (Pubitemid 36176812)
48. Pietrzak AT, Zalewska A, Chodorowska G, et al. Cytokines and anticytokines in psoriasis. Clin Chim Acta 2008; 394: 7-21.
49. Ohta Y, Hamada Y,. In situ expression of CD40 and CD40 ligand in psoriasis. Dermatology 2004; 209: 21-8. (Pubitemid 39179101)
50. Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348: 1104-11. (Pubitemid 36337321)
51. Varo N, de Lemos JA, Libby P, et al. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 2003; 108: 1049-52. (Pubitemid 37071512)
52. Wang Y, Wang L, Ai X, et al. Nicotine could augment adhesion molecule expression in human endothelial cells through macrophages secreting TNF-alpha, IL-1beta. Int Immunopharmacol 2004; 4: 1675-86. (Pubitemid 39348864)
53. Shepherd J, Little MC, Nicklin MJ,. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol 2004; 122: 665-9. (Pubitemid 38471334)
54. Garey KW, Neuhauser MM, Robbins RA, et al. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004; 125: 22-6. (Pubitemid 38114559)
55. Sonnex TS, Carrington P, Norris P, Greaves MW,. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers. Br J Dermatol 1988; 119: 653-9.
56. Grando SA, Crosby AM, Zelickson BD, Dahl MV,. Agarose gel keratinocyte outgrowth system as a model of skin re-epithelization: requirement of endogenous acetylcholine for outgrowth initiation. J Invest Dermatol 1993; 101: 804-10. (Pubitemid 23357489)
57. Grando SA, Horton RM, Mauro TM, et al. Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J Invest Dermatol 1996; 107: 412-18. (Pubitemid 26284352)
58. Grando SA, Horton RM, Pereira EF, et al. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol 1995; 105: 774-81. (Pubitemid 26006352)
59. De Angelis R, Bugatti L, Del Medico P, et al. Videocapillaroscopic findings in the microcirculation of the psoriatic plaque. Dermatology 2002; 204: 236-9. (Pubitemid 34628315)
60. Kulka JP,. Microcirculatory impairment as a factor in inflammatory tissue damage. Ann NY Acad Sci 1964; 116: 1018-44.
61. Campanati A, Goteri G, Simonetti O, et al. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. Int J Immunopathol Pharmacol 2009; 22: 371-7.
62. Detmar M, Brown LF, Schon MP, et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998; 111: 1-6. (Pubitemid 28309201)
63. Nofal A, Al-Makhzangy I, Attwa E, et al. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control. J Eur Acad Dermatol Venereol 2009; 23: 803-6.
64. Simonetti O, Lucarini G, Campanati A, et al. VEGF, survivin and NOS overexpression in psoriatic skin: critical role of nitric oxide synthases. J Dermatol Sci 2009; 54: 205-8.
65. Xia YP, Li B, Hylton D, et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003; 102: 161-8. (Pubitemid 36759650)
66. Kimura K, Hashiguchi T, Deguchi T, et al. Serum VEGF-as a prognostic factor of atherosclerosis. Atherosclerosis 2007; 194: 182-8. (Pubitemid 47464298)
67. Michaud SE, Dussault S, Haddad P, et al. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006; 187: 423-32. (Pubitemid 43963027)
68. Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001; 7: 833-9. (Pubitemid 32691639)
69. U.S. Department of Health and Human Services. 11th Report on Carcinogens. 2005. Available at: (last accessed 16 August 2011).
70. Sopori ML, Kozak W, Savage SM, et al. Nicotine-induced modulation of T cell function. Implications for inflammation and infection. Adv Exp Med Biol 1998; 437: 279-89.
71. Nizri E, Irony-Tur-Sinai M, Lory O, et al. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 2009; 183: 6681-8.
72. Schmitt-Egenolf M, Boehncke WH, Stander M, et al. Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB10701/2, -DQA10201, -DQB10303 extended haplotype. J Invest Dermatol 1993; 100: 749-52. (Pubitemid 23151233)
73. OMIM. Psoriasis Susceptibility 1; PSORS1. Available at: (last accessed 16 August 2011).
74. Gudjonsson JE, Karason A, Antonsdottir AA, et al. HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 2002; 118: 362-5. (Pubitemid 34158494)
75. Duffin KC, Freeny IC, Schrodi SJ, et al. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 2009; 129: 2777-83.
76. Jin Y, Yang S, Zhang F, et al. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China. J Eur Acad Dermatol Venereol 2009; 23: 132-7.
77. Kramer U, Esser C,. Cigarette smoking, metabolic gene polymorphism, and psoriasis. J Invest Dermatol 2006; 126: 693-4, author reply 695. (Pubitemid 43255662)
78. Zheng GY, Wei SC, Shi TL, Li YX,. Association between alcohol, smoking and HLA-DQA10201 genotype in psoriasis. Acta Biochim Biophys Sin (Shanghai) 2004; 36: 597-602.
79. Nebert DW, Petersen DD, Puga A,. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics 1991; 1: 68-78.